Lbp Am Sa Grows Stock Position in Danaher Co. (NYSE:DHR)

Lbp Am Sa boosted its stake in shares of Danaher Co. (NYSE:DHR) by 30.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,860 shares of the conglomerate’s stock after acquiring an additional 6,231 shares during the quarter. Lbp Am Sa’s holdings in Danaher were worth $6,166,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher in the 4th quarter worth $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the fourth quarter valued at about $31,000. Teachers Insurance & Annuity Association of America bought a new position in shares of Danaher during the third quarter valued at about $39,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher during the third quarter worth about $40,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Up 3.4 %

Shares of NYSE:DHR opened at $211.09 on Friday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a fifty day simple moving average of $220.07 and a two-hundred day simple moving average of $240.82. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70. The stock has a market capitalization of $150.87 billion, a price-to-earnings ratio of 39.98, a PEG ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business posted $2.09 EPS. On average, research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

DHR has been the topic of a number of research analyst reports. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Guggenheim started coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Barclays cut their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $277.76.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.